PT Kalbe Farma Tbk (KLBF):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PT Kalbe Farma Tbk (KLBF) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9944
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インドネシア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PT Kalbe Farma Tbk (Kalbe) provides a wide range of healthcare solutions. The company undertakes the development, manufacturing and distribution of prescription pharmaceutical products, consumer health products, nutritional products and healthcare services. Its product portfolio comprises branded and unbranded generic drugs, nutritional products, supplements and over-the-counter (OTC) drugs, energy drinks and other preventive products. Kalbe is also involved in marketing and trading of medical devices and provides distribution and logistics solutions for pharmaceuticals products in Indonesia. It has overseas branches and representative offices in ASEAN countries, Nigeria, and South Africa. The company serves hospitals, pharmacies and drug stores across Indonesia. Kalbe is headquartered in Jakarta, Indonesia.

PT Kalbe Farma Tbk (KLBF) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PT Kalbe Farma Tbk, Medical Devices Deals, 2012 to YTD 2018 9
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Kalbe Farma and Genexine Form Joint Venture 11
Licensing Agreements 12
Stemedica Cell Technologies Enters Into Licensing Agreement With PT Kalbe Farma 12
Acquisition 13
Kalbe Farma Plans To Acquire Health Food Company For US$41.2 Million 13
PT Kalbe Farma Tbk – Key Competitors 14
PT Kalbe Farma Tbk – Key Employees 15
PT Kalbe Farma Tbk – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 18
Recent Developments 19
Strategy And Business Planning 19
Feb 27, 2018: Kalbe Inaugurated Drugs Ingredients and Biological Products Factory 19
Government and Public Interest 21
May 03, 2018: Kalbe Supports Downstream-ing of Research in Indonesia 21
Other Significant Developments 23
Jan 18, 2017: Kalbe Develops Biosimilar Factory 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Key Facts, 2017 2
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PT Kalbe Farma Tbk, Deals By Therapy Area, 2012 to YTD 2018 8
PT Kalbe Farma Tbk, Medical Devices Deals, 2012 to YTD 2018 9
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kalbe Farma and Genexine Form Joint Venture 11
Stemedica Cell Technologies Enters Into Licensing Agreement With PT Kalbe Farma 12
Kalbe Farma Plans To Acquire Health Food Company For US$41.2 Million 13
PT Kalbe Farma Tbk, Key Competitors 14
PT Kalbe Farma Tbk, Key Employees 15
PT Kalbe Farma Tbk, Other Locations 16
PT Kalbe Farma Tbk, Subsidiaries 17
PT Kalbe Farma Tbk, Joint Venture 18

List of Figures
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PT Kalbe Farma Tbk, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[PT Kalbe Farma Tbk (KLBF):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Translational Drug Development LLC-製薬・医療分野:企業M&A・提携分析
    Summary Translational Drug Development LLC (TD2) is a drug development organization offers oncology treatments to cancer patients. The organization offers services which include regulatory affairs services, preclinical services, clinical services, and others. It also offers in vivo services, isogeni …
  • Celestica Inc.:企業の戦略・SWOT・財務情報
    Celestica Inc. - Strategy, SWOT and Corporate Finance Report Summary Celestica Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Union Bank of India:企業のM&A・事業提携・投資動向
    Union Bank of India - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Union Bank of India Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Kyowa Hakko Kirin Co., Ltd.:企業のM&A・事業提携・投資動向
    Kyowa Hakko Kirin Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kyowa Hakko Kirin Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Domestic & General Group Holdings Limited:企業の戦略・SWOT・財務情報
    Domestic & General Group Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Domestic & General Group Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • REV Group Inc (REVG):企業の財務・戦略的SWOT分析
    REV Group Inc (REVG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Diebold Nixdorf Inc (DBD):企業の財務・戦略的SWOT分析
    Diebold Nixdorf Inc (DBD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Teva Pharmaceutical Industries Ltd (TEVA)-製薬・医療分野:企業M&A・提携分析
    Summary Teva Pharmaceutical Industries Ltd (Teva) carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines in central nervous system (CNS), respiratory, cancer, women’s health and other therapy areas. The company off …
  • Alon USA Energy Inc (ALJ)-石油・ガス分野:企業M&A・提携分析
    Summary Alon USA Energy Inc (Alon USA), a subsdiary of Delek US Holdings, Inc., is a refiner and marketer of petroleum products. The products offered by the company include various grades of gasoline, diesel fuel, jet fuel, petrochemicals, petrochemical feedstocks, asphalt, and other petroleum-based …
  • LIG Nex1 Co., Ltd.:企業の戦略・SWOT・財務情報
    LIG Nex1 Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary LIG Nex1 Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • AnGes Inc (4563):企業の財務・戦略的SWOT分析
    AnGes Inc (4563) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Airports of Thailand Plc (AOT):企業の財務・戦略的SWOT分析
    Airports of Thailand Plc (AOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Pacific Hydro Pty Ltd:電力:M&Aディール及び事業提携情報
    Summary Pacific Hydro Pty Ltd (Pacific Hydro), a subsidiary of State Power Investment Corporation is an energy solutions provider that undertakes the development and operations of the renewable power projects. The company offers wind, hydro, solar and geothermal power projects at varying stages of d …
  • Clinical Innovations LLC-医療機器分野:企業M&A・提携分析
    Summary Clinical Innovations LLC (Clinical Innovations), a subsidiary of Pritzker Group Company is a medical device company that offers healthcare products for women and infants. The company offers products such as safety heelsticks, traxi panniculus retractor, ROM plus membrane testing, tamponade s …
  • Grain Processing Corp:企業の戦略的SWOT分析
    Grain Processing Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Cox Enterprises Inc:企業の戦略的SWOT分析
    Cox Enterprises Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • The Vanguard Group Inc:企業の戦略的SWOT分析
    The Vanguard Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Endo International Plc (ENDP)-医療機器分野:企業M&A・提携分析
    Summary Endo International Plc (Endo) is a specialty healthcare company that develops, manufactures and commercializes various branded pharmaceutical products, generic pharmaceuticals and other products through its operating companies including Endo Pharmaceuticals, Paladin Labs, Par Pharmaceutical, …
  • ViacomCBS Inc (VIAC):企業の財務・戦略的SWOT分析
    ViacomCBS Inc (VIAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Royal Bank of Canada:企業のM&A・事業提携・投資動向
    Royal Bank of Canada - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Royal Bank of Canada Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆